Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 14, 2026; 32(34): 120518
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.120518
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.120518
Figure 8 Lactoferrin and lysozyme abundance correlates with pathway activity and barrier protection.
A: Levels of tumor necrosis factor-α and interleukin-1β in cell supernatants; B: Western blot analysis of zonula occludens-1 and occludin; C and D: Pearson correlation analysis between lactoferrin/Lysozyme protein abundance and nuclear factor erythroid 2-related factor 2 expression; E and F: Pearson correlation analysis between lactoferrin/Lysozyme protein abundance and p-p65/t-p65 ratio. cP < 0.001. TNF-α: Tumor necrosis factor-α; IL-1β: Interleukin-1β; H/R: Hypoxia/reoxygenation; Nrf2: Nuclear factor erythroid 2-related factor 2; ZO-1: Zonula occludens-1; LTF: Lactoferrin; LYZ: Lysozyme.
- Citation: Yang G, Liu L. Lactation stage-dependent protective effects of human milk exosomes against intestinal ischemia-reperfusion injury via lactoferrin/lysozyme-mediated Nrf2/HO-1 and NF-κB pathways. World J Gastroenterol 2026; 32(34): 120518
- URL: https://www.wjgnet.com/1007-9327/full/v32/i34/120518.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i34.120518